Marc Mackey has been chosen to serve as executive vice president of digital surgery at Surgalign. Mackey will also assume leadership of the company's digital surgery team, which was formed following the acquisition of Holo Surgical in September 2020.

The Medtronic Extended infusion set for diabetes has been released in select European countries. "The Medtronic Extended infusion set introduces increased simplicity and convenience -- something we're looking to deliver across all of our products and services to help ease burden and enhance the experience for people wherever they are in their diabetes journey," said Julie Foster, Medtronic diabetes business VP of customer experience.

AstraZeneca and Sanguina are working together to develop a customized version of the latter's AnemoCheck Mobile app that would allow for bloodless blood testing of patients with anemia by analyzing photos of their nailbeds to measure hemoglobin levels.

An underwritten public offering of 2.9 million shares of common stock has brought in $149.7 million for Outset Medical.

New Mexico-based RingIR is developing a breath-based technology that can detect COVID-19 within seconds.

The FDA has given 510(k) clearance to Becton Dickinson for its Pristine Long-Term Hemodialysis Catheter.

European regulators have given CE mark approval to OncoSec Medical for its GenPulse, a part of the company's electroporation device platform that is used to treat solid tumors.

European regulators have given CE mark approval to Hemanext's Hemanext ONE Red Blood Cell processing and storage system, which limits carbon dioxide and oxygen levels in stored RBCs.

The FDA has released a guidance explaining how the agency plans to conduct remote interactive evaluations of pharmaceutical and biomedical research sites during the pandemic. The agency said it will consider the use of remote interactive evaluations for all of its drug inspection programs, and some of the tools that will be used during remote inspections include livestreaming video, teleconferencing and screen-sharing technologies.

Aon, in collaboration with other stakeholders, is offering a cargo insurance coverage program for COVID-19 vaccines that will use sensor data and analytics to manage risks. Aon said it would donate all revenues from the program to pandemic-related charities.